Theo dõi
Seyed Moayed Alavian
Seyed Moayed Alavian
Professor of Internal Medicine-Research Center,Middle East Liver Disease Center, tehran, Iran
Email được xác minh tại thc.ir - Trang chủ
Tiêu đề
Trích dẫn bởi
Trích dẫn bởi
Năm
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic …
SL James, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ...
The Lancet 392 (10159), 1789-1858, 2018
105432018
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and …
JD Stanaway, A Afshin, E Gakidou, SS Lim, D Abate, KH Abate, ...
The lancet 392 (10159), 1923-1994, 2018
6623*2018
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the …
T Vos, AA Abajobir, KH Abate, C Abbafati, KM Abbas, F Abd-Allah, ...
The Lancet 390 (10100), 1211-1259, 2017
63522017
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990 …
HH Kyu, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ...
The Lancet 392 (10159), 1859-1922, 2018
38312018
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ...
The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017
22022017
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ...
The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018
16592018
The changing epidemiology of viral hepatitis B in Iran
SM Alavian, F Fallahian, KB Lankarani
Journal of Gastrointestinal and Liver Diseases 16 (4), 403-406, 2007
3412007
Health literacy and the influencing factors: a study in five provinces of Iran
SA Tehrani Banihashemi, AA Haghdoost, MA Amirkhani, SM Alavian, ...
Strides in development of medical education 4 (1), 1-9, 2007
3072007
Effect of aerobic and resistance exercise training on liver enzymes and hepatic fat in Iranian men with nonalcoholic fatty liver disease
A Shamsoddini, V Sobhani, MEG Chehreh, SM Alavian, A Zaree
Hepatitis monthly 15 (10), e31434, 2015
2932015
Hepatitis B Virus infection in Iran: A systematic review
SM Alavian, B Hajarizadeh, M AHMADZADASL, A Kabir, LK BAGHERI
Hepatitis Monthly 8 (421), 281-294, 2008
2692008
Hepatitis D Virus Infection; Iran, Middle East and Central Asia
S Alavian
Hepatitis Monthly 5 (4), 137-143, 2005
269*2005
Hepatitis C virus in Iran: Epidemiology of an emerging infection
SM Alavian, P Adibi, MR ZALI
ARCHIVES OF IRANIAN MEDICINE 8 (2), 84-90, 2005
2422005
Hepatitis C risk factors in Iranian volunteer blood donors: A case–control study
SM Alavian, B Gholami, S Masarrat
Journal of Gastroenterology and Hepatology 17 (10), 1092-1097, 2002
2342002
The efficacy of Liv-52 on liver cirrhotic patients: a randomized, double-blind, placebo-controlled first approach
HF Huseini, SM Alavian, R Heshmat, MR Heydari, K Abolmaali
Phytomedicine 12 (9), 619-624, 2005
2302005
Health in the Islamic Republic of Iran, challenges and progresses
KB Lankarani, SM Alavian, P Peymani
Medical journal of the Islamic Republic of Iran 27 (1), 42, 2013
2122013
Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infecions in patients with beta-thalassemia in Iran: a multicenter study
SH MIRMOUMEN, SM Alavian, B Hajarizadeh, J Kafaei, B Yektaparast, ...
ARCHIVES OF IRANIAN MEDICINE 9 (4), 319-323, 2006
1992006
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
D Razavi-Shearer, I Gamkrelidze, C Pan, J Jia, T Berg, R Gray, YS Lim, ...
The lancet Gastroenterology & hepatology 8 (10), 879-907, 2023
1942023
Hepatoprotective effect of quercetin: From chemistry to medicine
S Miltonprabu, M Tomczyk, K Skalicka-Woźniak, L Rastrelli, M Daglia, ...
Food and Chemical Toxicology 108, 365-374, 2017
1942017
Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind …
SA Jazayeri-Tehrani, SM Rezayat, S Mansouri, M Qorbani, SM Alavian, ...
Nutrition & metabolism 16, 1-13, 2019
1922019
Apoptosis in liver diseases-detection and therapeutic applications
S Ghavami, M Hashemi, K Kadkhoda, SM Alavian, GH Bay, MJ Los
Medical science monitor 11 (11), RA337-RA345, 2005
1862005
Hệ thống không thể thực hiện thao tác ngay bây giờ. Hãy thử lại sau.
Bài viết 1–20